Cuprina Holdings (Cayman) Ltd. (CUPR): Bozor kapitallashuvining daromadga nisbati

Cuprina Holdings Limited (CUPR) brendining ramzi va logotipi

Cuprina Holdings (Cayman) Ltd (CUPR) surunkli yaralar uchun biomeditsina terapiyalarini joriy qilish orqali Osiyodagi o'z mavjudligini kengaytirmoqda. Biznes daromadlari innovatsion bog'lovchi vositalar va lichinkalardan olingan biologik mahsulotlar savdosiga asoslangan. Barqaror ishchi kapital va likvidlik koeffitsiyentlari operatsion faoliyatni qo'llab-quvvatlaydi. Savdo hajmi nisbatidagi narx koeffitsiyentini tahlil qilsak, 320.90 belgisi aktivning joriy bozor qiymatini ko'rsatishi ayon bo'ladi.

Cuprina Holdings (Cayman) Ltd. (CUPR): Narxning daromadga nisbati 17.05.2025dan 17.11.2026gacha

Cuprina Holdings (Cayman) Ltd (CUPR) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

Kompaniyaning umumiy tahlili:Cuprina Holdings (Cayman) Ltd., CUPR
Cuprina Holdings Limited brend mahsuloti

Cuprina Holdings (Cayman) Ltd (CUPR) kompaniyasining investitsiya jozibadorligini baholash uchun joriy bozor narxining adolatli ekanligini aniqlash muhimdir. Narxning savdoga nisbati investor daromadning bir birligi uchun qancha to'layotganini aks ettiradi, bu esa aktivlarning haddan tashqari qimmat baholanganligini aniqlash imkonini beradi. Singapurlik menejmentning ilm-fanga yo'naltirilgan biznesi uchun ushbu ko'rsatkich innovatsion davolash usullarini tijoratlashtirish samaradorligining o'lchovi bo'lib xizmat qiladi. Past qiymatlar haddan tashqari ko'p to'lash xavfini minimallashtiradi, garchi kritik minimum kapital stagnatsiyasi haqida signal berishi mumkin bo'lsa-da.

Cuprina Holdings (Cayman) Ltd raqobatchilari

HCA (HCA Healthcare) - Bozor kapitallashuvining daromadga nisbati|Tenet Healthcare Corporation - Kapitalizatsiyaning daromadga nisbati|Fresenius Medical (FMS) - Sotuvga nisbatan narx|Solventum Corp - P/S multiplikatori|Narxning sotuvga nisbati EHC|Universal Health Services (UHS) - Narxning daromadga nisbati|DaVita - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati RDNT|OPCH: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Bozor kapitallashuvining daromadga nisbati|National Vision - Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Progyny Inc (PGNY)|Ardent Health - P/S multiplikatori|Narx/daromad koeffitsiyenti Select Medical Corp SEM|ASTH: P/S multiplikatori|Kapitalizatsiya va daromad nisbati MD|USPH (US Physical Therapy Inc) - P/S multiplikatori|PNTG: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Sotuvga nisbatan narx|EOLS - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiya va daromad nisbati MDWD|Narxning daromadga nisbati biote Corp.|Sotuvga nisbatan narx thejoint.com JYNT|P/S multiplikatori DCGO|Kapitalizatsiyaning daromadga nisbati P3 Health PIII|P/S multiplikatori GANX (Gain Therapeutics Inc.)|P/S multiplikatori EUDA Health Holdings Limited EUDA|baselmedical.com - P/S multiplikatori|CLGN: Narxning daromadga nisbati|CCM: P/S multiplikatori|AMS: Kapitalizatsiyaning sotish hajmiga nisbati|MRM (MEDIROM Corp) - P/S multiplikatori|ALBT: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DHAI|Longevity Health Holdings - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati NewGenIvf Group Ltd NIVF|ATIP (atipt.com) - Narxning sotuvga nisbati|CMAX: Kapitalizatsiyaning daromadga nisbati|Sotuvga nisbatan narx Kindly Health|ModivCare (MODV) - Narxning daromadga nisbati|NVOS (novointegrated.com) - Narxning daromadga nisbati|SSY (SunLink Health Systems Inc.) - P/S multiplikatori|BACK (IMAC Holdings Inc) - Kapitalizatsiyaning sotish hajmiga nisbati